← Back to BNTC

Benitec Biopharma Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 14/05/2026Dec 2025Filed 14/05/2026Sep 2025Filed 14/05/2026Jun 2025Filed 20/03/2026Mar 2025Filed 14/05/2026Dec 2024Filed 14/05/2026Sep 2024Filed 14/05/2026Mar 2024Filed 14/05/2025
$0$0$0$0$0$0$0
−$12−$12−$9−$8.8−$15−$9.6−$5.1−$4.3
−$0.24−$0.26−$0.22−$0.21−$0.38−$0.26−$0.18−$0.23
4946424139372818

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.